Clinical interest of PPARs ligands
Author:
- 1 February 2004
- journal article
- review article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 30 (1) , 7-12
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Peroxisome proliferator-activated receptor-α activation and high-density lipoprotein metabolismThe American Journal of Cardiology, 2001
- PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathwayNature Medicine, 2001
- CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated ReceptorsCirculation, 2000
- Peroxisome Proliferator-Activated Receptors: Nuclear Control of MetabolismEndocrine Reviews, 1999
- Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiencyNature Genetics, 1999
- The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier diseaseNature Genetics, 1999
- Mechanism of Action of Fibrates on Lipid and Lipoprotein MetabolismCirculation, 1998
- Induction of the Acyl-Coenzyme A Synthetase Gene by Fibrates and Fatty Acids Is Mediated by a Peroxisome Proliferator Response Element in the C PromoterJournal of Biological Chemistry, 1995
- Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemiaAtherosclerosis, 1993
- Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart StudyJAMA, 1988